Macromill Embrain Co Ltd

Macromill Embrain maintains a strong liquidity position with KRW 9.51 billion in cash and equivalents, representing 20.4% of total assets, and a current ratio of 2.14, well above the industry median of 1.5. The company's price-to-book ratio of 1.47 suggests market valuation is in line with tangible asset value, while the negative EV/EBITDA of -28.14 reflects current unprofitability. Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of KRW 842 million and operating loss of KRW 1.26 billion, resulting in ROE of -3.22% and ROA of -1.81%. These figures contrast sharply with the industry median ROE of 8.5% and ROA of 4.2%. Gross margin of 15.4% (KRW 8.64 billion gross profit on KRW 56.16 billion revenue) lags behind the 22% median for professional information services. The company operates as a single-segment business with 100% revenue concentration in South Korea. This geographic focus exposes it to local economic conditions and regulatory changes, with no diversification benefits from international operations. Revenue growth has been negative in recent periods, with the company reporting KRW 56.16 billion in revenue. The outlook for the current fiscal year shows no improvement, with negative operating income persisting. Capital expenditures of KRW 1.72 billion were funded by operating cash flow of KRW 1.53 billion, leaving free cash flow negative at KRW 1.27 billion. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.25 is well below the industry median of 0.6, and its cash position covers 147% of total liabilities. No dilution sources were identified in recent filings, and the company has not issued shares in the past 12 months. Recent filings show no material events affecting operations or capital structure. The company's 10-K filing for the latest fiscal year details ongoing investments in digital research platforms and panel expansion, but no significant regulatory actions or litigation were disclosed. Transcript data from recent earnings calls indicates management remains focused on cost optimization and market share retention.